September 2026 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Response to ASX Price Query
- Avecho enters final stage of Phase III insomnia trial
- June 2026 Quarterly Activities Report & Appendix 4C
- Positive interim analysis advances Avecho Phase III insomnia program
- Positive interim results from Phase III insomnia program
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology